Your browser is no longer supported. Please, upgrade your browser.
DCTH [NASD]
Delcath Systems, Inc.
Index- P/E- EPS (ttm)-4.36 Insider Own1.00% Shs Outstand7.44M Perf Week-8.47%
Market Cap50.67M Forward P/E- EPS next Y-3.57 Insider Trans57.63% Shs Float7.17M Perf Month-15.82%
Income-27.30M PEG- EPS next Q-1.01 Inst Own28.10% Short Float5.71% Perf Quarter-29.14%
Sales2.00M P/S25.33 EPS this Y97.60% Inst Trans0.14% Short Ratio4.35 Perf Half Y-29.14%
Book/sh1.55 P/B4.39 EPS next Y8.00% ROA-86.60% Target Price23.80 Perf Year-58.98%
Cash/sh3.35 P/C2.03 EPS next 5Y15.00% ROE-158.50% 52W Range6.97 - 25.18 Perf YTD-12.13%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-72.95% Beta0.43
Dividend %- Quick Ratio5.80 Sales past 5Y-1.20% Gross Margin61.80% 52W Low-2.37% ATR0.48
Employees43 Current Ratio6.00 Sales Q/Q0.00% Oper. Margin- RSI (14)32.51 Volatility4.59% 6.18%
OptionableNo Debt/Eq1.32 EPS Q/Q19.30% Profit Margin- Rel Volume0.47 Prev Close7.02
ShortableYes LT Debt/Eq1.32 EarningsNov 09 BMO Payout- Avg Volume94.09K Price6.81
Recom1.60 SMA20-11.43% SMA50-22.32% SMA200-32.57% Volume43,370 Change-2.99%
Dec-10-21Initiated H.C. Wainwright Buy $25
Mar-09-21Initiated Canaccord Genuity Buy $24
Jan-05-21Initiated BTIG Research Buy $23
Jun-01-20Initiated Laidlaw Buy $19
Jan-07-22 09:00AM  
Dec-02-21 08:00AM  
Nov-30-21 08:30AM  
Nov-11-21 06:06AM  
Nov-09-21 07:30AM  
Nov-08-21 12:49PM  
09:00AM  
Nov-05-21 09:00AM  
Nov-02-21 03:02PM  
Oct-25-21 04:01PM  
Sep-02-21 09:00AM  
Aug-10-21 07:30AM  
Aug-09-21 07:30AM  
Aug-05-21 09:00AM  
Aug-03-21 03:00PM  
Jul-28-21 09:00AM  
Jul-08-21 11:20AM  
Jul-07-21 09:00AM  
Jun-23-21 09:35AM  
Jun-08-21 09:00AM  
Jun-07-21 12:21PM  
07:30AM  
Jun-03-21 09:00AM  
May-26-21 09:00AM  
May-24-21 06:17AM  
May-11-21 08:00AM  
05:45AM  
May-03-21 02:33AM  
Apr-30-21 04:01PM  
09:00AM  
Apr-21-21 08:38AM  
Mar-31-21 02:55PM  
08:06AM  
07:45AM  
07:30AM  
05:45AM  
Mar-24-21 04:01PM  
Mar-08-21 09:00AM  
Feb-11-21 09:00AM  
Jan-11-21 10:56AM  
Dec-11-20 10:31AM  
Dec-09-20 08:00AM  
Dec-08-20 04:01PM  
Dec-07-20 07:30AM  
Nov-11-20 08:00AM  
Nov-02-20 04:01PM  
09:00AM  
Oct-29-20 07:30AM  
Oct-01-20 04:07PM  
Sep-28-20 10:50AM  
Sep-10-20 09:00AM  
Sep-02-20 05:36PM  
Aug-25-20 04:01PM  
Aug-13-20 04:01PM  
Aug-06-20 04:01PM  
Aug-05-20 09:00AM  
Aug-03-20 01:48PM  
May-26-20 08:30AM  
May-19-20 08:30AM  
May-15-20 06:30AM  
May-05-20 04:05PM  
May-01-20 10:17AM  
Feb-19-20 08:30AM  
Jan-13-20 08:30AM  
Dec-19-19 08:30AM  
Dec-03-19 08:30AM  
Oct-22-19 07:27AM  
Oct-18-19 08:00AM  
Oct-15-19 08:00AM  
Oct-08-19 08:00AM  
Sep-23-19 11:30AM  
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO includes the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma; and the ALIGN trial, a Phase 3 clinical trial for intrahepatic cholangiocarcinoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SALAMON STEVEN A JDirectorDec 30Buy7.562,00015,120421,500Jan 03 02:04 PM
Rosalind Advisors, Inc.DirectorDec 30Buy7.562,00015,120423,500Jan 03 02:02 PM
MICHEL GERARD JSee RemarksDec 02Buy8.6123,200199,75259,050Dec 06 06:06 PM
SALAMON STEVEN A JDirectorJun 30Buy12.765,50070,180419,500Jul 01 10:47 AM
SALAMON STEVEN A JDirectorJun 28Buy11.565,00057,800414,000Jun 30 09:53 AM
MICHEL GERARD JChief Executive OfficerJun 28Buy11.936,25074,56235,850Jun 29 01:46 PM
MICHEL GERARD JChief Executive OfficerJun 25Buy11.356,60074,91029,600Jun 29 01:46 PM
SALAMON STEVEN A JDirectorJun 24Buy10.904,50049,050409,000Jun 28 08:50 AM
Purpura JohnChief Operating OfficerMay 13Buy9.424,00037,68018,713May 14 08:06 AM
MICHEL GERARD JChief Executive OfficerApr 05Buy12.8815,500199,64023,000Apr 05 12:34 PM